Renaissance Technologies - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q2 2018$1,227,0000.0%528,9130.0%0.00%0.0%
Q1 2018$1,227,000
+62.7%
528,913
+8.7%
0.00%0.0%
Q4 2017$754,000
-13.9%
486,613
+18.3%
0.00%0.0%
Q3 2017$876,000
-44.7%
411,413
+17.3%
0.00%
-50.0%
Q2 2017$1,585,000
+107.7%
350,713
+38.4%
0.00%
+100.0%
Q1 2017$763,000
+28.7%
253,413
+17.9%
0.00%0.0%
Q4 2016$593,000
+16.5%
215,013
+32.2%
0.00%0.0%
Q3 2016$509,000
+10.2%
162,613
+80.3%
0.00%0.0%
Q2 2016$462,000
+73.0%
90,213
+38.1%
0.00%0.0%
Q1 2016$267,000
-47.1%
65,313
+5.0%
0.00%0.0%
Q4 2015$505,000
-10.1%
62,213
-6.6%
0.00%0.0%
Q3 2015$562,000
-34.8%
66,613
-27.3%
0.00%
-50.0%
Q2 2015$862,000
-4.1%
91,647
-5.6%
0.00%0.0%
Q1 2015$899,000
+26.1%
97,113
+25.9%
0.00%0.0%
Q4 2014$713,000
-5.1%
77,113
-8.3%
0.00%0.0%
Q3 2014$751,000
-33.2%
84,113
-41.3%
0.00%
-33.3%
Q2 2014$1,125,000
-35.5%
143,298
-35.0%
0.00%
-25.0%
Q1 2014$1,745,000
+27.9%
220,613
+0.8%
0.00%
+33.3%
Q4 2013$1,364,000
+83.3%
218,913
+4.2%
0.00%
+50.0%
Q3 2013$744,000
+90.8%
210,113
+5.2%
0.00%
+100.0%
Q2 2013$390,000199,8130.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Alistair Capital Management, L.L.C. 917,400$5,715,0002.56%
Fortress Investment Group LLC 2,481,596$15,460,0000.24%
PERKINS CAPITAL MANAGEMENT INC 14,000$87,0000.06%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,332,260$8,386,0000.02%
TFS CAPITAL LLC 26,116$163,0000.01%
GROUP ONE TRADING, L.P. 54,815$342,0000.01%
Renaissance Technologies 218,913$1,364,0000.00%
Alberta Investment Management Corp 19,140$128,0000.00%
OAK RIDGE INVESTMENTS LLC 11,055$69,0000.00%
CLEAR STREET MARKETS LLC 600$4,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders